Jennifer E. Cook Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

Jennifer E. Cook is Director of Jazz Pharmaceuticals plc. Currently has a direct ownership of 10,837 shares of JAZZ, which is worth approximately $1.23 Million. The most recent transaction as insider was on Aug 08, 2025, when has been sold 1,805 shares (Ordinary Shares) at a price of $111.25 per share, resulting in proceeds of $200,806. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.8K

18.63% 3M change

18.63% 12M change

Total Value Held $1.23 Million

Jennifer E. Cook Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 08 2025	SELL Payment of exercise price or tax liability	$200,806 $111.25 p/Share	1,805 Reduced 14.28%	10,837 Ordinary Shares
Aug 07 2025	BUY Grant, award, or other acquisition	-	3,507 Added 21.72%	12,642 Ordinary Shares
Aug 06 2024	SELL Payment of exercise price or tax liability	$165,243 $111.35 p/Share	1,484 Reduced 13.97%	9,135 Ordinary Shares
Aug 02 2024	BUY Grant, award, or other acquisition	-	3,731 Added 26.0%	10,619 Ordinary Shares
Dec 04 2023	SELL Open market or private sale	$49,735 $119.27 p/Share	417 Reduced 5.71%	6,888 Ordinary Shares
Aug 14 2023	SELL Open market or private sale	$171,456 $138.16 p/Share	1,241 Reduced 14.52%	7,305 Ordinary Shares
Aug 11 2023	BUY Grant, award, or other acquisition	-	3,075 Added 26.46%	8,546 Ordinary Shares
Dec 02 2022	SELL Open market or private sale	$64,965 $154.68 p/Share	420 Reduced 7.13%	5,471 Ordinary Shares
Aug 08 2022	SELL Open market or private sale	$165,876 $152.32 p/Share	1,089 Reduced 15.6%	5,891 Ordinary Shares
Aug 05 2022	BUY Grant, award, or other acquisition	-	2,561 Added 26.84%	6,980 Ordinary Shares
Dec 02 2021	SELL Open market or private sale	$50,582 $121.3 p/Share	417 Reduced 8.62%	4,419 Ordinary Shares
Jul 29 2021	BUY Grant, award, or other acquisition	-	2,246 Added 31.71%	4,836 Ordinary Shares
Feb 25 2021	BUY Grant, award, or other acquisition	-	2,590 Added 50.0%	2,590 Ordinary Shares

Also insider at

BBIO

BridgeBio Pharma, Inc. Healthcare

DNLI

Denali Therapeutics Inc. Healthcare

Director

JEC

Jennifer E. Cook

Director

Dublin 4, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Value

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ

Account